Menu
Who we help / Community Oncology Practices
Your patients shouldn’t have to travel hours to an academic center for CAR-T or bispecifics. Current Health gives community practices proven outpatient models, 24/7 support from nurses drawn from ED and ICU, and coordinated escalation to your hospital partner, so you can treat locally without adding overnight staff.
1,500+
advanced therapy episodes
20,000+
advanced therapy patient monitoring days
80%
of patient issues resolved without site escalation at Sarah Cannon
60
peer-reviewed papers and abstracts
The access gap
Most people with cancer are treated close to home, but CAR-T has stayed concentrated in academic centers, and bispecific step-up dosing often still means a hospital stay. For CAR-T, that is starting to change: in June 2025, FDA removed the REMS for approved CD19- and BCMA-directed autologous CAR-T therapies and cut the recommended post-infusion stay-nearby period from 4 weeks to 2. As indications move into earlier lines of treatment, more of your patients become eligible, and distance too often decides who gets treated.
~85%
of US cancer patients receive care in community settings
National Cancer Institute
40%
less likely to receive CAR-T when patients live 2–4 hours from a treatment center
Ahmed et al., TCT 2024
The challenges we help solve
When CAR-T or a bispecific means a trip to an academic center, you risk losing the relationship and the continuity of care you’ve built. Bispecific patients admitted or referred out for step-up dosing may not come back for their maintenance doses, labs, and supportive care. Offering treatment locally keeps patients with the team they know.
Without integrated monitoring and adverse event management, the ED becomes the default, and an unnecessary admission can send a patient elsewhere for good. Our nurses resolve what your protocol and standing orders say is safe to manage at home. When a patient needs more, they page your escalation contact per protocol or arrange a planned admission to your hospital partner, calling ahead so the receiving team is ready. If you don’t have a hospital partner yet, we help you find one.
After-hours triage, patient and caregiver education, protocols, kit logistics, and quality reporting add up fast for a practice that isn’t staffed overnight. Current Health takes most of that work on, from 24/7 nursing and kit logistics to program launch, so your on-call team is called when your protocol says a patient needs them.
Programs that need daily visits can only treat patients close to the clinic. Monitoring and nurse support at home let you widen your radius safely.
When step-up dosing or CAR-T means a hospital stay, the hospital bills for it. Treat in your practice, and infusion and follow-up are billed by your practice, as are step-up doses where each label and your protocol allow. There’s no 24/7 toxicity nursing team to build in-house.
Our models
Our models for bispecifics and CAR-T come ready to run, with evidence-based protocols, implementation and training handled by our team, and the same 24/7 Clinical Coordination Center behind every patient.
Without overburdening or having to expand your staff. Passive monitoring of multiple signals, patented CRS detection, and virtual ICANS assessments, with 24/7 nurse coordination, so patients recover at home or in local lodging through the highest-risk weeks.
90%
of CAR-T patients made eligible for outpatient care at Sarah Cannon
App check-ins for temperature, blood pressure, oxygen saturation, and symptoms, virtual ICE assessments, and nurse oversight around the clock through step-up dosing. Escalation protocols defined with your hospital partner give every patient a clear path to care.
89%
of patients who began step-up dosing outpatient reached full dose at Memorial Sloan Kettering
When a patient needs care
Where your protocol and a standing order allow, our nurses start treatment, such as directing patients to take medications you’ve prescribed in advance, so not every event needs escalation. When a patient needs hospital care, our nurses coordinate the admission, arrange transport, and call ahead so the receiving team knows who is coming and why.
Treatment started under your standing orders and protocols
Multilingual team with live translation on calls and chat
Nurses drawn from ED and ICU, licensed in all 50 states
01
Infusion or dose delivered locally, by your team.
02
Monitoring and 24/7 nurse oversight. Our nurses respond first and treat per your protocols and standing orders.
03
Your escalation contact paged per protocol, a planned admission arranged with your hospital partner, straight to the floor where your agreement allows, and the receiving team called ahead with a toxicity summary.
04
Every call and escalation recorded in our dashboard, from alarm and assessment to order and outcome, and written back to your EHR.
05
Discharge notes returned to your EHR where your hospital agreement provides, and the patient continues care with your team.
Before go-live
Start from our evidence-based escalation protocols. Your team fills in roles and responsibilities and approves them, so everyone knows who gets the call and when. If you don’t have a hospital partner for escalations, we can help through our network of advanced therapy treatment centers.
Our protocols already define what our nurses treat under your standing orders, what goes to your escalation contact, and what becomes a planned admission. You assign the roles and sign off, or customize to your team’s preference.
We bring the agreement template and admission criteria, coordinate handoffs to ED or hospital teams, and call ahead with a toxicity summary on every escalation.
What your team owns, what we take on, and how we get your program live, from protocols and hospital partners to follow-up after treatment.
Program support
Asked what patients need most to receive advanced therapies in community settings, oncology clinicians and administrators put after-hours triage and at-home monitoring at the top. That is the support we bring to your practice, along with the program experience academic centers spent years building.
70%
of oncology clinicians and administrators chose after-hours triage support as a top patient support need
Clinical pathways, workflows, escalation protocols with your hospital partner, staff training, and go-live, handled with your team.
Program build, preparation for FACT accreditation, and support through manufacturer site qualification.
Program dashboards that show your outcomes to practice leadership, referring physicians, and payers.
Practice economics
Step-up doses given in your infusion center are billed by your practice, not a hospital. Patients stay with you for maintenance doses, labs, and supportive care, and CAR-T follow-up stays with your practice too.
Our nurses cover nights, weekends, and holidays, so there’s no 24/7 toxicity nursing to build in-house. Monitoring may be billable under remote physiologic monitoring codes.
The economics are site specific, so our site enablement team builds a five-year financial model with you before you commit, based on your expected patient volume, payer mix, the therapies you plan to offer, and your referral network.
What’s behind every model
Our nurses, drawn from ED and ICU, assess, escalate per your protocols, arrange transfers, start treatment under your standing orders, and document every interaction, around the clock.
2 min
to reach a patient or caregiver about an alarm
Passive monitoring of multiple signals, patented CRS detection, and virtual ICE assessments help detect adverse events earlier than relying on patients to call with concerns. Support from our 24/7 Clinical Coordination Center enables patients to recover at home or in local lodging through the highest-risk weeks.
7 hrs
median earlier recognition of CRS than standard inpatient nursing care
Mount Sinai
Experience managing older patients with other conditions at home, and adherence that holds across age groups.
95.3%
median wearable adherence in patients 75+
Pugmire et al., Age and Ageing, 2024
Program results
5 sites
The same model runs across five CAR-T products and sites of different sizes and geographies.1
100%
Monitoring flagged every CRS event, so patients were escalated when they needed care and stayed home when they didn’t.2
83%
Median wearable adherence held steady across age groups, including patients in their 80s.3
“Partnering with Current Health has allowed us to safely transition CAR-T to an outpatient setting, supporting patients beyond the hospital walls, without compromising safety, quality of care, or clinical oversight.”
Navneet Majhail, MD, FASTCT
Physician-in-Chief, Blood Cancers, Sarah Cannon Cancer Network
Tell us what you’re working on, and we’ll help you find the right place to start.